Literature DB >> 19073968

Regulation of CD151 by hypoxia controls cell adhesion and metastasis in colorectal cancer.

Chun-Wei Chien1, Shih-Chieh Lin, Yen-Yu Lai, Bo-Wen Lin, Shao-Chieh Lin, Jenq-Chang Lee, Shaw-Jenq Tsai.   

Abstract

PURPOSE: The first step of metastasis is the detachment of cancer cells from the surrounding matrix and neighboring cells; however, how cancer cells accomplish this process remains unclear. Thus, we aimed to investigate the underlying mechanism that controls the early event of metastasis. EXPERIMENTAL
DESIGN: One hundred and thirty-seven paired colorectal carcinoma and normal colon tissues were examined by immunohistochemical staining and Western blot for the expression of CD151, a member of the tetraspanin family that plays important roles in cell adhesion and motility. The effect of CD151 on cancer cell adhesion was investigated under normoxia and hypoxia conditions.
RESULTS: The level of CD151 was down-regulated in colon cancer compared with the paired normal counterparts. Expression of CD151 was negatively regulated by hypoxia inducible factor-1-dependent hypoxic stress. Suppression of CD151 by hypoxia caused the detachment of cancer cells from the surrounding matrix and neighboring cells whereas restoration of CD151 expression during reoxygenation facilitated the adhesion capacity. Clinical examination further showed that metastasized cancer cells expressed a greater level of CD151 compared with that of primary tumor.
CONCLUSION: Regulation of CD151 by oxygen tension may play an important role in cancer metastasis by regulating the detachment from the primary site and homing in the secondary site.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073968     DOI: 10.1158/1078-0432.CCR-08-1651

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  30 in total

1.  Suppression of dual-specificity phosphatase-2 by hypoxia increases chemoresistance and malignancy in human cancer cells.

Authors:  Shih-Chieh Lin; Chun-Wei Chien; Jenq-Chang Lee; Yi-Chun Yeh; Keng-Fu Hsu; Yen-Yu Lai; Shao-Chieh Lin; Shaw-Jenq Tsai
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

2.  Tetraspanin CD151 protects against pulmonary fibrosis by maintaining epithelial integrity.

Authors:  Kazuyuki Tsujino; Yoshito Takeda; Toru Arai; Yasushi Shintani; Ryosaku Inagaki; Hiroyuki Saiga; Takeo Iwasaki; Satoshi Tetsumoto; Yingji Jin; Shoichi Ihara; Toshiyuki Minami; Mayumi Suzuki; Izumi Nagatomo; Koji Inoue; Hiroshi Kida; Takashi Kijima; Mari Ito; Masanori Kitaichi; Yoshikazu Inoue; Isao Tachibana; Kiyoshi Takeda; Meinoshin Okumura; Martin E Hemler; Atsushi Kumanogoh
Journal:  Am J Respir Crit Care Med       Date:  2012-05-16       Impact factor: 21.405

Review 3.  Tetraspanin proteins promote multiple cancer stages.

Authors:  Martin E Hemler
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

4.  Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer.

Authors:  Chun-Wun Lu; Shau-Chieh Lin; Chun-Wei Chien; Shih-Chieh Lin; Chung-Ta Lee; Bo-Wen Lin; Jenq-Chang Lee; Shaw-Jenq Tsai
Journal:  Am J Pathol       Date:  2011-07-18       Impact factor: 4.307

5.  CD151: Basis Sequence: Mouse.

Authors:  Trenis D Palmer; Andries Zijlstra
Journal:  AFCS Nat Mol Pages       Date:  2011

6.  Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines.

Authors:  Zhiyu Zhang; Lijun Zhang; Yingqi Hua; Xiaofang Jia; Jian Li; Shuo Hu; Xia Peng; Pengyuan Yang; Mengxiong Sun; Fang Ma; Zhengdong Cai
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

7.  CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.

Authors:  Julie C Nienstedt; Alexander Gröbe; Patrick Lebok; Franziska Büscheck; Till Clauditz; Ronald Simon; Asmus Heumann; Guido Sauter; Christoph Moebius; Adrian Münscher; Rainald Knecht; Marco Blessmann; Max Heiland; Christina Pflug
Journal:  Clin Oral Investig       Date:  2016-07-21       Impact factor: 3.573

8.  Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer.

Authors:  C-W Chien; P-C Hou; H-C Wu; Y-L Chang; S-C Lin; S-C Lin; B-W Lin; J-C Lee; Y-J Chang; H S Sun; S-J Tsai
Journal:  Oncogene       Date:  2016-05-02       Impact factor: 9.867

Review 9.  The emerging role of circulating tumor cells in cancer management.

Authors:  Xue-Yao Li; Man Dong; Xiang-Yang Zang; Miao-Ya Li; Jing-Yi Zhou; Jian-Jun Ma; Gang-Yang Wang
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

10.  CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasion.

Authors:  Shannin C Zevian; Jessica L Johnson; Nicole E Winterwood; Katherine S Walters; Mary E Herndon; Michael D Henry; Christopher S Stipp
Journal:  Cancer Biol Ther       Date:  2015-09-29       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.